Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 65% · stale
- Computed at
- 2026-07-27T18:59:05.383864+00:00
- Claimed
- 80
- Reported
- 78
- Verified
- 70
- Gap
- +10
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-07-27
Proceed with caution
- Why
- Clinically validated by a peer-reviewed-context, FDA-reviewed pivotal trial (Up-LIFT) and now dual-cleared (clinic + home use) with CE marking, but real-world adoption is still small-scale and unprofitable in its first commercial year, and broad payer reimbursement is not yet confirmed — durable clinical proof, not yet durable market proof.
- Next
- Re-check FY2026 commercial metrics (units sold, clinic count, payer/reimbursement coverage) before citing ARC-EX as the settled non-invasive-category anchor in bioelectronics thesis narratives; watch ARC-IM (implanted) BCI pivotal 'Empower BP' trial as the company's next readiness milestone.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 5
- Tier 1
- 0
- Tier 2
- 3
- Tier 3
- 2
- Supports
- 4
- Contradicts
- 1
- Context
- 0
- Latest observed
- 2026-03-31
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-07-27 Reading moved from ready to ready.